84-2397-13 [取扱停止]SLU7 (Pre-mRNA-Splicing Factor SLU7, hSlu7) 100ul 225883
特徴
- In order to produce correctly spliced messenger RNA, two catalytic splicing steps are required.
- After catalytic step I, a major remodeling of the spliceosome occurs to establish the active site for step II.
- During the second step of mRNA splicing, exon 1 attacks an adenine-guanine (AG) dinucleotide at the 3' splice site.
- SLU7, the human homolog of the yeast step II splice factor Slu7, is required for selection of the correct AG.
- Human SLU7 associates with the spliceosome late in the splicing pathway prior to recognition of the 3' splice site for step II.
- SLU7 depletion in HeLa nuclear extract reveals that SLU7 is required to hold exon 1 tightly within the spliceosome for attack on a prespecified AG.
- Applications:Suitable for use in Western Blot.
- Other applications not tested.
- Recommended Dilution:Western Blot: 1:500-1:1000Optimal dilutions to be determined by the researcher.
- Storage and Stability:May be stored at 4°C for short-term only.
- Aliquot to avoid repeated freezing and thawing.
- Store at -20°C.
- Aliquots are stable for 12 months after receipt.
- For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
- Size:100ul
- Host:rabbit
- Source Antibody:human
- Grade:Affinity Purified
- Purity:Purified by immunoaffinity chromatography.
- Form:Supplied as a liquid PBS, 0.05% sodium azide, pH 7.2.
- Specificity:Recognizes endogenous levels of SLU7. Species Crossreactivity: Human, mouse, rat
- Isotype:IgG
- Calc Applications Abbrev:WB
- Calc Crossreactivity:Hu Mo Rt
- Immunogen:Synthetic peptide corresponding to amino acids 154-199 of Human SLU7.
- Shelf Life:1year
- Swiss Prot Number:O95391
- EU Commodity Code:30021010
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL:06-6447-8641
- FAX:06-6447-8642
- E-mail:[email protected]